glp 1 and parkinson's Incretin insulin signaling as novel therapeutic targets for Alzheimer's and disease Adjusted cumulative incidence of incident

Novel evidence for a greater burden of ambient air pollution on cardiovascular disease

Metabolic syndrome among type 2 diabetic patients in sub-Saharan African countries: a systematic review and meta-analysis

In the case of PT-141, a growing body of research and case data supports its safety and effectiveness in male patients, especially those for whom PDE5 inhibitors have failed

Wilson disease (WD) is an orphan, inherited, progressive and severely debilitating disorder of copper metabolism which is lethal if left untreated

The Benefits Individually & Together When used individually, both peptides provide impressive benefits

By preventing the breakdown of GLP-1 and prolonging its circulation, TEN antinociceptive action was partially counteracted by the GLP-1R antagonist exendin-3, suggesting GLP-1R-independent mechanisms